- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03686007
Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients
A Multimedia Self-management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
Study Overview
Status
Conditions
Detailed Description
PRIMARY OBJECTIVES:
I. Test the effects of the multimedia self-management (MSM) intervention on family caregivers (FCG) outcomes and cancer support services use at discharge and 3-month post-discharge, comparing intervention and attention control groups.
II. Test the effects of the MSM intervention on patient outcomes and healthcare resource use at discharge and 3-months post-discharge, comparing intervention and attention control groups.
III. Test the effects of the MSM intervention on outcome mediators at discharge and 3-months post-discharge, comparing intervention and attention control groups.
SECONDARY OBJECTIVES:
I. Explore moderators (age, sex, marital status, caregiver relationship to patient, caregiver employment status, co-morbidities) of FCG and patient outcomes and reciprocal relationships.
II. Determine, through exit interviews, participant's experience with the MSM intervention.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive research nurse support by telephone (separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge.
GROUP II: Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a clinical research associate (CRA) approximately 3-7 days before surgery and within 24 hours of planned discharge. Patients and FCGs also receive assistance from CRAs via telephone calls at 2 and 7 days, and 2 months post-discharge.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Duarte, California, United States, 91010
- City of Hope Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Family Caregiver Inclusion Criteria:
- A family member or friend identified by the patient as being the primary care provider before and after surgery
- A patient/care recipient enrolled in the study
- Age 21 years or older
- Able to read or understand English
Patient Inclusion Criteria:
- Diagnosis of Stage I-III non-small cell lung cancer
- Scheduled to undergo surgery for treatment
- A family caregiver enrolled in the study
- Age 21 years or older
- Able to read or understand English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group I (MSM intervention)
Patients and FCGs receive the MSM intervention consisting of videos, a handbook, and research nurse coaching over 40-60 minutes, approximately 3-7 days before surgery and within 24 hours of planned discharge.
Patients and FCGs also receive research nurse support via telephone(separate sessions for FCGs and patients) over 20-30 minutes at 2 and 7 days, and 2 months post-discharge.
|
Ancillary studies
Other Names:
Ancillary studies
Receive MSM intervention handbook
Receive MSM intervention research nurse coaching
Receive ASCO print materials
Receive CRA assistance
View the MSM intervention videos
View ASCO Cancer.net videos
|
Active Comparator: Group II (Attention Control)
Patients and FCGs receive attention control intervention consisting of videos (American Cancer Society video on "Clinical Trials"), American Cancer Society print materials, and assistance from a CRA approximately 3-7 days before surgery and within 24 hours of planned discharge.
Patients and FCGs also receive assistance from CRAs via telephone at 2 and 7 days, and 2 months post-discharge.
|
Receive MSM intervention handbook
Receive MSM intervention research nurse coaching
Receive ASCO print materials
Receive CRA assistance
View the MSM intervention videos
View ASCO Cancer.net videos
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in family caregiver psychological distress (as measured by the Distress Thermometer)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in caregiving burden (as measured by the Montgomery Borgatta Caregiver Burden Scale)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in preparedness for caregiving (as measured by the Preparedness for Caregiving Scale)
Time Frame: outcomes are measured before surgery (baseline), 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured before surgery (baseline), 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in family caregiver quality of life (as measured by the City of Hope-Quality of Life-Family (COH-QOL-Family)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in family caregiver resource use (as measured by the Family Caregiver Healthcare Use Inventory)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in patient psychological distress (as measured by the Distress Thermometer)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in patient quality of life (as measured by the Functional Assessment of Cancer Therapy-Lung - FACT-L)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in patient healthcare resource use (home health nursing care, urgent/ER visits, hospital readmissions)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in family caregiver and patient self-efficacy (as measured by the Self-Efficacy Scale)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in family caregiver activation (as measured by the FCG Activation in Transitions Tool)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in patient activation (as measured by the Patient Activation Measure)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Change in family caregiver and patient knowledge (as measured by the Surgery-Related Knowledge Tool)
Time Frame: outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
outcomes are measured at baseline, 1 day before discharge, 1 month, and 3 months post-discharge
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Virginia Sun, RN, PhD, City of Hope Medical Center
- Principal Investigator: Jae Kim, MD, City of Hope Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17238 (Other Identifier: City of Hope Medical Center)
- NCI-2017-01391 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caregiver
-
Case Comprehensive Cancer CenterWithdrawnCaregiver Distress | Caregiver Anxiety | Caregiver Health Related QOL
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesRecruitingCaregiver Burnout | Caregiver Stress | Care Giving Burden | Caregiver Wellbeing | Support, Family | Care BurdenUnited States
-
TC Erciyes UniversityCompletedCaregiver Stress Syndrome | Caregiver Burnout | ReikiTurkey
-
Case Western Reserve UniversityCompletedDistress | CaregiverUnited States
-
Medical University of South CarolinaUniversity of DelawareCompletedBurnout, CaregiverUnited States
-
Washington University School of MedicineCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingCaregiver Burden | Caregiver Stress Syndrome | Caregiver BurnoutUnited States
-
University of PennsylvaniaNational Institute on Aging (NIA)Recruiting
-
Duke UniversityCompletedCaregiver WellbeingUnited States
-
Istituto Nazionale di Ricovero e Cura per AnzianiEuropean CommissionCompletedCaregiver | Aging ProblemsItaly, Netherlands, Switzerland
Clinical Trials on Quality-of-Life Assessment
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Malignant NeoplasmUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChildhood Malignant NeoplasmUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Malignant Ovarian Epithelial Tumor | Ovarian Carcinosarcoma | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditionsUnited States
-
Wake Forest University Health SciencesWithdrawnLung Metastases | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma
-
City of Hope Medical CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Neuropathy | COVID-19 InfectionUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingCervical Carcinoma | Endometrial Carcinoma | Vaginal Carcinoma | Malignant Female Reproductive System Neoplasm | Vulvar CarcinomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 and other conditionsUnited States